fluoxetine and drospirenone

fluoxetine has been researched along with drospirenone in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Gricar, J; Rendas-Baum, R; Wallenstein, GV; Yang, M	1
El Wahed, HAA; Fahim, AS; Hussein, GK; Katta, MA; Moety, GAFA; Shehata, NAA	1

Trials

1 trial(s) available for fluoxetine and drospirenone

Article	Year
Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial. Reproductive sciences (Thousand Oaks, Calif.), 2020, Volume: 27, Issue:2 Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Premenstrual Syndrome; Treatment Outcome	2020

Article

Year

Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial.

Reproductive sciences (Thousand Oaks, Calif.), 2020, Volume: 27, Issue:2

Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Premenstrual Syndrome; Treatment Outcome

2020

Other Studies

2 other study(ies) available for fluoxetine and drospirenone

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder. Applied health economics and health policy, 2010, Volume: 8, Issue:2 Topics: Androstenes; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Fluoxetine; Humans; Mineralocorticoid Receptor Antagonists; Models, Economic; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2010

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.

Applied health economics and health policy, 2010, Volume: 8, Issue:2

Topics: Androstenes; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Fluoxetine; Humans; Mineralocorticoid Receptor Antagonists; Models, Economic; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

2010